CNX-011-67, a novel GPR40 agonist, enhances glucose responsiveness, insulin secretion and islet insulin content in n-STZ rats and in islets from type 2 diabetic patients
Authors:
- Venkategowda SunilVSVenkategowda Sunil
- Mahesh Kumar VermaMVMahesh Kumar Verma
- Anup M OommenAnup M Oommen
- Manojkumar SadasivuniMSManojkumar Sadasivuni
- Jaideep SinghJSJaideep Singh
- Dasarahalli N VijayraghavDVDasarahalli N Vijayraghav
- Bhawna ChandravanshiBCBhawna Chandravanshi
- Jayalaxmi ShettyJSJayalaxmi Shetty
- Sanghamitra BiswasSBSanghamitra Biswas
- Anilkumar DanduADAnilkumar Dandu
- Yoganand MoolemathYMYoganand Moolemath
- Marikunte V VenkatarangannaMVMarikunte V Venkataranganna
Open Access
- 25 March 2014
- journal article
- Published by Springer Nature in BMC Pharmacology and Toxicology
- Vol. 15 (1) , 19
Abstract
GPR40 is a G-protein coupled receptor regulating free fatty acid induced and also glucose induced insulin secretion. We generated neonatally-streptozotocin-treated female rats (n-STZ) and treated them with CNX-011-67, a GPR40 agonist to examine the role of GPR40 in modulation of glucose metabolism, insulin secretion and content.Keywords
This publication has 62 references indexed in Scilit:
- TAK‐875, a GPR40/FFAR1 agonist, in combination with metformin prevents progression of diabetes and β‐cell dysfunction in Zucker diabetic fatty ratsBritish Journal of Pharmacology, 2013
- Chronic glucolipotoxic conditions in pancreatic islets impair insulin secretion due to dysregulated calcium dynamics, glucose responsiveness and mitochondrial activityBMC Cell Biology, 2013
- Treatment with CNX-011-67, a novel GPR40 agonist, delays onset and progression of diabetes and improves beta cell preservation and function in male ZDF ratsBMC Pharmacology and Toxicology, 2013
- TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trialThe Lancet, 2012
- The Effects of TAK-875, a Selective G Protein-Coupled Receptor 40/Free Fatty Acid 1 Agonist, on Insulin and Glucagon Secretion in Isolated Rat and Human IsletsThe Journal of Pharmacology and Experimental Therapeutics, 2012
- AMG 837: A Novel GPR40/FFA1 Agonist that Enhances Insulin Secretion and Lowers Glucose Levels in RodentsPLOS ONE, 2011
- Evidence that low-grade systemic inflammation can induce islet dysfunction as measured by impaired calcium handlingCell Calcium, 2010
- Overexpression of GPR40 in Pancreatic β-Cells Augments Glucose-Stimulated Insulin Secretion and Improves Glucose Tolerance in Normal and Diabetic MiceDiabetes, 2009
- Glucose Modulates [Ca2+]i Oscillations in Pancreatic Islets via Ionic and Glycolytic MechanismsBiophysical Journal, 2006
- Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small moleculesBritish Journal of Pharmacology, 2006